Abiopharma

Monster Beverage to Report Financial Results for 2026 Second Quarter on August 6, 2026

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026

Veritone Adds Document Redaction to Create an All-in-One, AI-Powered Redaction Suite

Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041

Armstrong World Industries Appoints Jennifer Kozak to Senior Vice President, Chief Human Resources Officer

Leidos and CoreWeave collaborate to accelerate delivery of AI capabilities for defense, national security and intelligence missions

Asset Acquisitions and Disposals: ANNOUCEMENT PURSUANT TO RULE 706A OF THE CATALIST RULES

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

Curis Doses First Five Patients in TakeAim CLL Study

General Announcement: Press Release